Health Care and Societal Costs of Bronchopulmonary Dysplasia
- PMID: 33384574
- PMCID: PMC7773141
- DOI: 10.1542/neo.19-4-e211
Health Care and Societal Costs of Bronchopulmonary Dysplasia
Abstract
Despite significant technological advances and increasing survival of premature infants, bronchopulmonary dysplasia (BPD) continues to be the most prevalent major morbidity in surviving very low-birthweight infants. Infants with BPD are often sicker, require longer stays in the NICU, and accumulate greater hospital costs. However, care of the infant with BPD extends beyond the time spent in the NICU. This article reviews the costs of BPD in the health-care setting, during the initial hospitalization and beyond, and the long-term neurodevelopmental impact of BPD, as well as the impact on a family caring for a child with BPD.
Figures
References
-
- Ferré C, Callaghan W, Olson C, Sharma A, Barfield W. Effects of maternal age and age-specific preterm birth rates on overall preterm birth rates-United States, 2007 and 2014. MMWR Morb Mortal Wkly Rep. 2016;65(43):1181–1184 - PubMed
-
- Horbar JD, Carpenter JH, Badger GJ, et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics. 2012;129(6):1019–1026 - PubMed
-
- Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med. 1967;276(7):357–368 - PubMed
-
- Lapcharoensap W, Gage SC, Kan P, et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr. 2015;169(2):e143676. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
